2012
DOI: 10.3109/15412555.2012.667850
|View full text |Cite
|
Sign up to set email alerts
|

Predictors of Osteoporosis and Vertebral Fractures in Patients Presenting with Moderate-to-Severe Chronic Obstructive Lung Disease

Abstract: Bone mineral density (BMD) alone does not reliably predict osteoporotic fractures. The Fracture Risk Assessment Tool (FRAX) was developed to estimate the risk of fracture in the general population. This study was designed to identify predictors of osteoporosis and vertebral fractures in patients presenting with chronic obstructive pulmonary disease (COPD). We studied 85 patients (mean age = 75 years; 92% men) with moderate to very severe COPD. Osteoporosis and vertebral fractures were diagnosed with dual energ… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
52
2
1

Year Published

2012
2012
2020
2020

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 50 publications
(56 citation statements)
references
References 21 publications
1
52
2
1
Order By: Relevance
“…The prevalence of VFs in our study population (21.6% of the COPD subjects had !1 VF at baseline and 33.5% at 3-year followup) was at the somewhat lower range compared with prevalence of most COPD reports found in literature (mostly 24% to 45%, (23)(24)(25)(26)(27)(28)(29)(30)32) with outliers of 9.0% (15) and 79.4% (31) ). This could probably be explained by the fact that the subjects in this study were not using oral GC at baseline because of study design (subjects using oral GC at baseline were excluded, and only 23 and 47 subjects, respectively, reported oral GC use at 1-year and 3-year follow-up), whereas in most (12% to 86% (15,(25)(26)(27)(29)(30)(31)(32) GC use) but not all (2.2% to 4.5% (23,24,28) GC use) studies, the percentage of subjects using GCs was considerably higher.…”
Section: Comparison To Published Researchmentioning
confidence: 52%
See 2 more Smart Citations
“…The prevalence of VFs in our study population (21.6% of the COPD subjects had !1 VF at baseline and 33.5% at 3-year followup) was at the somewhat lower range compared with prevalence of most COPD reports found in literature (mostly 24% to 45%, (23)(24)(25)(26)(27)(28)(29)(30)32) with outliers of 9.0% (15) and 79.4% (31) ). This could probably be explained by the fact that the subjects in this study were not using oral GC at baseline because of study design (subjects using oral GC at baseline were excluded, and only 23 and 47 subjects, respectively, reported oral GC use at 1-year and 3-year follow-up), whereas in most (12% to 86% (15,(25)(26)(27)(29)(30)(31)(32) GC use) but not all (2.2% to 4.5% (23,24,28) GC use) studies, the percentage of subjects using GCs was considerably higher.…”
Section: Comparison To Published Researchmentioning
confidence: 52%
“…This could probably be explained by the fact that the subjects in this study were not using oral GC at baseline because of study design (subjects using oral GC at baseline were excluded, and only 23 and 47 subjects, respectively, reported oral GC use at 1-year and 3-year follow-up), whereas in most (12% to 86% (15,(25)(26)(27)(29)(30)(31)(32) GC use) but not all (2.2% to 4.5% (23,24,28) GC use) studies, the percentage of subjects using GCs was considerably higher.…”
Section: Comparison To Published Researchmentioning
confidence: 80%
See 1 more Smart Citation
“…Therefore, early identification of high-risk patients is an important step toward increasing treatment rates. However, relying on BMD screening alone is not considered sufficient to detect high-risk patients in a timely and cost-effective manner (Ogura-Tomomatsu et al, 2012; Schuit et al, 2004). …”
Section: Introductionmentioning
confidence: 99%
“…Since that time a number of interesting manuscripts have been published that expand this area. In this issue of COPD: Journal of Chronic Obstructive Pulmonary Disease, a group of researchers from Japan studied a small, predominantly male COPD cohort to probe what factors predict vertebral fractures in COPD subjects (3). Th e paper highlights the reason that we screen for osteoporosis or bone loss: What is the future fracture risk?…”
mentioning
confidence: 98%